Is there cumulative or delayed toxicity from Cis‐platinum?

Diana Chiuten, Steven Vogl, Barry Kaplan, Fernando J. Camacho

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Evidence of increasing risk of nephrotoxicity was sought in the records of 95 patients who had received 300–826 mg/m2 cumulative doses of cis‐platinum in single doses of 50–75 mg/m2 every 3–4 weeks, with hydration and diuresis using mannitol and furosemide. The incidence of serum creatinine elevation to >1.5 mg/dl was 4.2% per patient and 0.75% per dose, no higher than the incidence observed at lower cumulative doses. Among 54 of these patients observed for at least 3 months after cessation of cis‐platinum chemotherapy, only one had later deterioration of renal function to a serum creatinine of 1.9; both kidneys had been irradiated to 1900 rad in this patient. It was concluded that cumulative, delayed or severe nephrotoxicity are not significant problems related to prolonged cis‐platinum administration at moderate doses when hydration and diuretics are routinely used.

Original languageEnglish (US)
Pages (from-to)211-214
Number of pages4
JournalCancer
Volume52
Issue number2
DOIs
StatePublished - Jan 1 1983

Fingerprint

Creatinine
Kidney
Diuresis
Incidence
Furosemide
Mannitol
Serum
Diuretics
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Is there cumulative or delayed toxicity from Cis‐platinum? / Chiuten, Diana; Vogl, Steven; Kaplan, Barry; Camacho, Fernando J.

In: Cancer, Vol. 52, No. 2, 01.01.1983, p. 211-214.

Research output: Contribution to journalArticle

Chiuten, Diana ; Vogl, Steven ; Kaplan, Barry ; Camacho, Fernando J. / Is there cumulative or delayed toxicity from Cis‐platinum?. In: Cancer. 1983 ; Vol. 52, No. 2. pp. 211-214.
@article{f56221937b734bf9a67aa94a24bc5899,
title = "Is there cumulative or delayed toxicity from Cis‐platinum?",
abstract = "Evidence of increasing risk of nephrotoxicity was sought in the records of 95 patients who had received 300–826 mg/m2 cumulative doses of cis‐platinum in single doses of 50–75 mg/m2 every 3–4 weeks, with hydration and diuresis using mannitol and furosemide. The incidence of serum creatinine elevation to >1.5 mg/dl was 4.2{\%} per patient and 0.75{\%} per dose, no higher than the incidence observed at lower cumulative doses. Among 54 of these patients observed for at least 3 months after cessation of cis‐platinum chemotherapy, only one had later deterioration of renal function to a serum creatinine of 1.9; both kidneys had been irradiated to 1900 rad in this patient. It was concluded that cumulative, delayed or severe nephrotoxicity are not significant problems related to prolonged cis‐platinum administration at moderate doses when hydration and diuretics are routinely used.",
author = "Diana Chiuten and Steven Vogl and Barry Kaplan and Camacho, {Fernando J.}",
year = "1983",
month = "1",
day = "1",
doi = "10.1002/1097-0142(19830715)52:2<211::AID-CNCR2820520205>3.0.CO;2-U",
language = "English (US)",
volume = "52",
pages = "211--214",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Is there cumulative or delayed toxicity from Cis‐platinum?

AU - Chiuten, Diana

AU - Vogl, Steven

AU - Kaplan, Barry

AU - Camacho, Fernando J.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - Evidence of increasing risk of nephrotoxicity was sought in the records of 95 patients who had received 300–826 mg/m2 cumulative doses of cis‐platinum in single doses of 50–75 mg/m2 every 3–4 weeks, with hydration and diuresis using mannitol and furosemide. The incidence of serum creatinine elevation to >1.5 mg/dl was 4.2% per patient and 0.75% per dose, no higher than the incidence observed at lower cumulative doses. Among 54 of these patients observed for at least 3 months after cessation of cis‐platinum chemotherapy, only one had later deterioration of renal function to a serum creatinine of 1.9; both kidneys had been irradiated to 1900 rad in this patient. It was concluded that cumulative, delayed or severe nephrotoxicity are not significant problems related to prolonged cis‐platinum administration at moderate doses when hydration and diuretics are routinely used.

AB - Evidence of increasing risk of nephrotoxicity was sought in the records of 95 patients who had received 300–826 mg/m2 cumulative doses of cis‐platinum in single doses of 50–75 mg/m2 every 3–4 weeks, with hydration and diuresis using mannitol and furosemide. The incidence of serum creatinine elevation to >1.5 mg/dl was 4.2% per patient and 0.75% per dose, no higher than the incidence observed at lower cumulative doses. Among 54 of these patients observed for at least 3 months after cessation of cis‐platinum chemotherapy, only one had later deterioration of renal function to a serum creatinine of 1.9; both kidneys had been irradiated to 1900 rad in this patient. It was concluded that cumulative, delayed or severe nephrotoxicity are not significant problems related to prolonged cis‐platinum administration at moderate doses when hydration and diuretics are routinely used.

UR - http://www.scopus.com/inward/record.url?scp=0020534133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020534133&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19830715)52:2<211::AID-CNCR2820520205>3.0.CO;2-U

DO - 10.1002/1097-0142(19830715)52:2<211::AID-CNCR2820520205>3.0.CO;2-U

M3 - Article

VL - 52

SP - 211

EP - 214

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -